OPERA LTD-ADR (OPRA) Fundamental Analysis & Valuation

NASDAQ:OPRAUS68373M1071

Current stock price

14.47 USD
+0.01 (+0.07%)
At close:
14.47 USD
0 (0%)
After Hours:

This OPRA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. OPRA Profitability Analysis

1.1 Basic Checks

  • In the past year OPRA was profitable.
  • In the past year OPRA had a positive cash flow from operations.
  • OPRA had positive earnings in 4 of the past 5 years.
  • OPRA had a positive operating cash flow in each of the past 5 years.
OPRA Yearly Net Income VS EBIT VS OCF VS FCFOPRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

1.2 Ratios

  • The Return On Assets of OPRA (9.47%) is better than 84.48% of its industry peers.
  • The Return On Equity of OPRA (10.71%) is better than 75.09% of its industry peers.
  • With a decent Return On Invested Capital value of 7.57%, OPRA is doing good in the industry, outperforming 79.06% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for OPRA is below the industry average of 10.89%.
  • The 3 year average ROIC (7.18%) for OPRA is below the current ROIC(7.57%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.47%
ROE 10.71%
ROIC 7.57%
ROA(3y)10.76%
ROA(5y)5.96%
ROE(3y)11.99%
ROE(5y)6.66%
ROIC(3y)7.18%
ROIC(5y)N/A
OPRA Yearly ROA, ROE, ROICOPRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • OPRA has a better Profit Margin (17.62%) than 83.03% of its industry peers.
  • In the last couple of years the Profit Margin of OPRA has declined.
  • OPRA's Operating Margin of 14.98% is amongst the best of the industry. OPRA outperforms 82.31% of its industry peers.
  • In the last couple of years the Operating Margin of OPRA has grown nicely.
  • OPRA has a Gross Margin (64.11%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of OPRA has declined.
Industry RankSector Rank
OM 14.98%
PM (TTM) 17.62%
GM 64.11%
OM growth 3Y3.33%
OM growth 5Y77.52%
PM growth 3Y57.33%
PM growth 5Y-29.54%
GM growth 3Y-8.44%
GM growth 5Y-7.62%
OPRA Yearly Profit, Operating, Gross MarginsOPRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80 100

8

2. OPRA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OPRA is destroying value.
  • Compared to 1 year ago, OPRA has an improved debt to assets ratio.
OPRA Yearly Shares OutstandingOPRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
OPRA Yearly Total Debt VS Total AssetsOPRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • OPRA has an Altman-Z score of 7.67. This indicates that OPRA is financially healthy and has little risk of bankruptcy at the moment.
  • OPRA has a Altman-Z score of 7.67. This is amongst the best in the industry. OPRA outperforms 86.64% of its industry peers.
  • OPRA has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
  • OPRA has a better Debt to FCF ratio (0.07) than 81.95% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that OPRA is not too dependend on debt financing.
  • OPRA has a better Debt to Equity ratio (0.00) than 66.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Altman-Z 7.67
ROIC/WACC0.85
WACC8.93%
OPRA Yearly LT Debt VS Equity VS FCFOPRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 2.35 indicates that OPRA has no problem at all paying its short term obligations.
  • OPRA has a better Current ratio (2.35) than 64.98% of its industry peers.
  • OPRA has a Quick Ratio of 2.35. This indicates that OPRA is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of OPRA (2.35) is better than 65.70% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.35
OPRA Yearly Current Assets VS Current LiabilitesOPRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

8

3. OPRA Growth Analysis

3.1 Past

  • OPRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.49%, which is quite good.
  • The Earnings Per Share has been growing by 22.48% on average over the past years. This is a very strong growth
  • Looking at the last year, OPRA shows a very strong growth in Revenue. The Revenue has grown by 27.21%.
  • The Revenue has been growing by 28.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)16.49%
EPS 3Y67.61%
EPS 5Y22.48%
EPS Q2Q%7.14%
Revenue 1Y (TTM)27.21%
Revenue growth 3Y22.84%
Revenue growth 5Y28.32%
Sales Q2Q%21.52%

3.2 Future

  • OPRA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.46% yearly.
  • Based on estimates for the next years, OPRA will show a quite strong growth in Revenue. The Revenue will grow by 14.86% on average per year.
EPS Next Y30.11%
EPS Next 2Y22.83%
EPS Next 3Y19.8%
EPS Next 5Y20.46%
Revenue Next Year20.67%
Revenue Next 2Y18.22%
Revenue Next 3Y15.9%
Revenue Next 5Y14.86%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
OPRA Yearly Revenue VS EstimatesOPRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
OPRA Yearly EPS VS EstimatesOPRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1 2 3

8

4. OPRA Valuation Analysis

4.1 Price/Earnings Ratio

  • OPRA is valuated correctly with a Price/Earnings ratio of 12.81.
  • Compared to the rest of the industry, the Price/Earnings ratio of OPRA indicates a rather cheap valuation: OPRA is cheaper than 84.48% of the companies listed in the same industry.
  • OPRA is valuated cheaply when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 9.84, the valuation of OPRA can be described as reasonable.
  • 85.56% of the companies in the same industry are more expensive than OPRA, based on the Price/Forward Earnings ratio.
  • OPRA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.84.
Industry RankSector Rank
PE 12.81
Fwd PE 9.84
OPRA Price Earnings VS Forward Price EarningsOPRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OPRA indicates a rather cheap valuation: OPRA is cheaper than 88.81% of the companies listed in the same industry.
  • OPRA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. OPRA is cheaper than 86.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.56
EV/EBITDA 10.36
OPRA Per share dataOPRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • OPRA has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as OPRA's earnings are expected to grow with 19.80% in the coming years.
PEG (NY)0.43
PEG (5Y)0.57
EPS Next 2Y22.83%
EPS Next 3Y19.8%

5

5. OPRA Dividend Analysis

5.1 Amount

  • OPRA has a Yearly Dividend Yield of 5.39%, which is a nice return.
  • Compared to an average industry Dividend Yield of 0.59, OPRA pays a better dividend. On top of this OPRA pays more dividend than 97.11% of the companies listed in the same industry.
  • OPRA's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 5.39%

5.2 History

  • OPRA has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
OPRA Yearly Dividends per shareOPRA Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • OPRA pays out 65.72% of its income as dividend. This is not a sustainable payout ratio.
DP65.72%
EPS Next 2Y22.83%
EPS Next 3Y19.8%
OPRA Yearly Income VS Free CF VS DividendOPRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M
OPRA Dividend Payout.OPRA Dividend Payout, showing the Payout Ratio.OPRA Dividend Payout.PayoutRetained Earnings

OPRA Fundamentals: All Metrics, Ratios and Statistics

OPERA LTD-ADR

NASDAQ:OPRA (3/13/2026, 8:00:02 PM)

After market: 14.47 0 (0%)

14.47

+0.01 (+0.07%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-26
Earnings (Next)04-27
Inst Owners19.15%
Inst Owner Change3.15%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.30B
Revenue(TTM)614.45M
Net Income(TTM)108.28M
Analysts83.08
Price Target25.57 (76.71%)
Short Float %7.19%
Short Ratio4.04
Dividend
Industry RankSector Rank
Dividend Yield 5.39%
Yearly Dividend0.57
Dividend Growth(5Y)N/A
DP65.72%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-07
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.94%
Min EPS beat(2)-22.87%
Max EPS beat(2)-11.01%
EPS beat(4)1
Avg EPS beat(4)-6.76%
Min EPS beat(4)-22.87%
Max EPS beat(4)8.78%
EPS beat(8)3
Avg EPS beat(8)-6.02%
EPS beat(12)6
Avg EPS beat(12)40.8%
EPS beat(16)7
Avg EPS beat(16)-5.98%
Revenue beat(2)2
Avg Revenue beat(2)2.93%
Min Revenue beat(2)0.56%
Max Revenue beat(2)5.29%
Revenue beat(4)4
Avg Revenue beat(4)3.36%
Min Revenue beat(4)0.56%
Max Revenue beat(4)6.51%
Revenue beat(8)6
Avg Revenue beat(8)2.04%
Revenue beat(12)9
Avg Revenue beat(12)1.47%
Revenue beat(16)13
Avg Revenue beat(16)2.24%
PT rev (1m)0%
PT rev (3m)-1.68%
EPS NQ rev (1m)-9.45%
EPS NQ rev (3m)3.29%
EPS NY rev (1m)-9.6%
EPS NY rev (3m)-2.05%
Revenue NQ rev (1m)7.2%
Revenue NQ rev (3m)7.01%
Revenue NY rev (1m)5.27%
Revenue NY rev (3m)4.98%
Valuation
Industry RankSector Rank
PE 12.81
Fwd PE 9.84
P/S 2.11
P/FCF 11.56
P/OCF 11.02
P/B 1.28
P/tB 2.69
EV/EBITDA 10.36
EPS(TTM)1.13
EY7.81%
EPS(NY)1.47
Fwd EY10.16%
FCF(TTM)1.25
FCFY8.65%
OCF(TTM)1.31
OCFY9.08%
SpS6.85
BVpS11.27
TBVpS5.37
PEG (NY)0.43
PEG (5Y)0.57
Graham Number16.93
Profitability
Industry RankSector Rank
ROA 9.47%
ROE 10.71%
ROCE 8.98%
ROIC 7.57%
ROICexc 8.92%
ROICexgc 22.82%
OM 14.98%
PM (TTM) 17.62%
GM 64.11%
FCFM 18.26%
ROA(3y)10.76%
ROA(5y)5.96%
ROE(3y)11.99%
ROE(5y)6.66%
ROIC(3y)7.18%
ROIC(5y)N/A
ROICexc(3y)8.27%
ROICexc(5y)N/A
ROICexgc(3y)22.13%
ROICexgc(5y)N/A
ROCE(3y)8.52%
ROCE(5y)N/A
ROICexgc growth 3Y14.94%
ROICexgc growth 5Y134.47%
ROICexc growth 3Y22.52%
ROICexc growth 5Y130.89%
OM growth 3Y3.33%
OM growth 5Y77.52%
PM growth 3Y57.33%
PM growth 5Y-29.54%
GM growth 3Y-8.44%
GM growth 5Y-7.62%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Debt/EBITDA 0.04
Cap/Depr 29.4%
Cap/Sales 0.9%
Interest Coverage 150.85
Cash Conversion 106.18%
Profit Quality 103.6%
Current Ratio 2.35
Quick Ratio 2.35
Altman-Z 7.67
F-Score7
WACC8.93%
ROIC/WACC0.85
Cap/Depr(3y)65.11%
Cap/Depr(5y)44.73%
Cap/Sales(3y)2.09%
Cap/Sales(5y)1.53%
Profit Quality(3y)85.76%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.49%
EPS 3Y67.61%
EPS 5Y22.48%
EPS Q2Q%7.14%
EPS Next Y30.11%
EPS Next 2Y22.83%
EPS Next 3Y19.8%
EPS Next 5Y20.46%
Revenue 1Y (TTM)27.21%
Revenue growth 3Y22.84%
Revenue growth 5Y28.32%
Sales Q2Q%21.52%
Revenue Next Year20.67%
Revenue Next 2Y18.22%
Revenue Next 3Y15.9%
Revenue Next 5Y14.86%
EBIT growth 1Y-0.39%
EBIT growth 3Y26.93%
EBIT growth 5Y127.8%
EBIT Next Year88.94%
EBIT Next 3Y36.85%
EBIT Next 5Y28.05%
FCF growth 1Y37.42%
FCF growth 3Y28.02%
FCF growth 5Y4.84%
OCF growth 1Y12.15%
OCF growth 3Y27.61%
OCF growth 5Y4.76%

OPERA LTD-ADR / OPRA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of OPERA LTD-ADR (OPRA) stock?

ChartMill assigns a fundamental rating of 8 / 10 to OPRA.


What is the valuation status of OPERA LTD-ADR (OPRA) stock?

ChartMill assigns a valuation rating of 8 / 10 to OPERA LTD-ADR (OPRA). This can be considered as Undervalued.


Can you provide the profitability details for OPERA LTD-ADR?

OPERA LTD-ADR (OPRA) has a profitability rating of 7 / 10.


How financially healthy is OPERA LTD-ADR?

The financial health rating of OPERA LTD-ADR (OPRA) is 8 / 10.


What is the earnings growth outlook for OPERA LTD-ADR?

The Earnings per Share (EPS) of OPERA LTD-ADR (OPRA) is expected to grow by 30.11% in the next year.